23s rrna

Erythromycin (E-Mycin) is a Macrolide and Macrolide Antimicrobial. The physiologic effect of erythromycin is by means of Decreased Sebaceous Gland Activity.

Clindamycin Phosphate is the phosphate salt form of clindamycin, a semi-synthetic, chlorinated broad-spectrum antibiotic produced by chemical modification of lincomycin. Clindamycin phosphate (Clindamycin 2-dihydrogen phosphate) is used in topical preparations.

Azithromycin hydrate (CP-62993 dihydrate) is a semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.

3-Methyluridine is a modified nucleoside of cellular RNA.

Clindamycin hydrochloride monohydrate (Clindamycin alcoholate) is a protein synthesis inhibitor used orally, capable of diminishing virulence factor expression in Staphylococcus aureus at sub-minimum inhibitory concentrations (sub-MICs). It acts by suppressing Panton-Valentine leucocidin (PVL), toxic-shock-staphylococcal toxin (TSST-1), and alpha-haemolysin (Hla) production. Resistance to this compound emerges through enzymatic methylation at the antibiotic's 50S ribosomal subunit binding site (23S rRNA).

SEQ-9 is an orally active inhibitor of the Mycobacterium tuberculosis (Mtb) 23S bacterial ribosome, with an inhibitory concentration (IC50) around 170 nM against unmethylated Mtb ribosomes and potent effects on A2296 methylated ribosomes. It is used in research on bacterial infections and drug resistance [1].

Clindamycin-d3 (hydrochloride) is the deuterated form of Clindamycin. Clindamycin is an orally active, broad-spectrum lincosamide antibiotic that efficiently inhibits bacterial protein synthesis. It can suppress the expression of virulence factors in Staphylococcus aureus at sub-inhibitory concentrations (sub-MICs). Resistance to Clindamycin arises from the enzymatic methylation of the antibiotic binding site on the 50S ribosomal subunit (23S rRNA). It also reduces the production of leukocidin (PVL), toxic shock syndrome toxin-1 (TSST-1), and α-hemolysin (Hla). Additionally, Clindamycin is utilized in malaria research.

Clindamycin hydrochloride monohydrate (Standard) is the standard substance of Clindamycin hydrochloride monohydrate, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Clindamycin hydrochloride monohydrate (Clindamycin alcoholate) is a protein synthesis inhibitor used orally, capable of diminishing virulence factor expression in Staphylococcus aureus at sub-minimum inhibitory concentrations (sub-MICs). It acts by suppressing Panton-Valentine leucocidin (PVL), toxic-shock-staphylococcal toxin (TSST-1), and alpha-haemolysin (Hla) production. Resistance to this compound emerges through enzymatic methylation at the antibiotic's 50S ribosomal subunit binding site (23S rRNA).